SUBSCRIBE
SUBSCRIBE

RareCyte

IN THE PRESS
BioForest
RareCyte® Inc. reports significant 2021 growth of Precision Biology™ Services business and customer uptake of Orion™ Spatial Biology instruments and reagents
January 6, 2022
 · 
2 min read
BioForest
RareCyte® Secures $24M Financing to Advance the Orion™ Spatial Biology Platform and Expand Global Commercial Channels
September 9, 2021
 · 
2 min read
BioForest
RareCyte announces first commercially available ARv7/Synaptophysin CTC assay for blood-based characterization of treatment resistant prostate cancer
August 26, 2020
 · 
2 min read
BioForest
RareCyte® announces the Orion™ spatial biology platform with breakthrough technology for same-day highly multiplexed tissue analysis
July 16, 2020
 · 
2 min read
BioForest
RareCyte announces the first blood-to-result PD-L1 Circulating Tumor Cell Assay
February 27, 2020
 · 
2 min read
BioForest
RareCyte Closes $22M Financing for Global Commercialization and Platform Expansion into Tissue Multiplexing
December 19, 2019
 · 
4 min read
BioForest
RareCyte expands liquid biopsy offering with the release of a HER2/ER breast cancer CTC Panel Kit
October 31, 2019
 · 
2 min read
BioForest
RareCyte launches prostate cancer ARv7 CTC Kit for liquid biopsy analysis
October 30, 2019
 · 
1 min read
BioForest
New RarePlex Developer Kits for CTC characterization provide researchers flexibility in independent CTC assay development
October 29, 2019
 · 
2 min read
BioForest
RareCyte introduces comprehensive CyteFinder II platform for fast, multiplexed imaging that enables multi-omic results for liquid biopsy and tissue analysis
March 28, 2019
 · 
2 min read
Load More
JOBS